Log in to save to my catalogue

Continued anti-VEGF treatment does not prevent recurrences in eyes with stable neovascular age-relat...

Continued anti-VEGF treatment does not prevent recurrences in eyes with stable neovascular age-relat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8956692

Continued anti-VEGF treatment does not prevent recurrences in eyes with stable neovascular age-related macular degeneration using a treat-and-extend regimen: a retrospective case series

About this item

Full title

Continued anti-VEGF treatment does not prevent recurrences in eyes with stable neovascular age-related macular degeneration using a treat-and-extend regimen: a retrospective case series

Publisher

London: Nature Publishing Group UK

Journal title

Eye (London), 2022-04, Vol.36 (4), p.862-868

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background
The continuation of anti-vascular endothelial growth factor (anti-VEGF) treatment after achieving stability in patients with neovascular age-related macular degeneration has generally been advocated. In our own patients, we thought to assess whether continued anti-VEGF treatment is capable of preventing recurrences.
Methods
In t...

Alternative Titles

Full title

Continued anti-VEGF treatment does not prevent recurrences in eyes with stable neovascular age-related macular degeneration using a treat-and-extend regimen: a retrospective case series

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8956692

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8956692

Other Identifiers

ISSN

0950-222X

E-ISSN

1476-5454

DOI

10.1038/s41433-021-01562-6

How to access this item